Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Been thinking

You wrote:

Wasn't there a solicitation for pledges in order to achieve a shareholder-led change to the BoD? From memory, I think that it achieved pledges in excess of 10% of the o/s - corrections more than welcomed.

I don't know of any such solicitation. Perhaps someone else does.

Anyway....do you think it could work? Would you be on board with the idea?

Tks

Share
New Message
Please login to post a reply